Acadia Healthcare Q1 revenue up 14.2% to $704.3M; affirms FY 2023 guidance

Acadia Healthcare Company, Inc.

2023-Q1 EPS reported $0.72 revenue$704,267,000

Revenue $704.3M (+14.2% YoY); same-facility revenue +13.3% on 6.5% more patient days and 6.4% higher revenue per day.
Net income $66.0M ($0.72 diluted EPS); adjusted income $68.7M ($0.75 diluted EPS).
Adjusted EBITDA $151.3M, +11.6% YoY; cash and revolver availability of $548.8M, net leverage 2.2x.
FY 2023 guidance affirmed: revenue $2.82-2.88B, Adj. EBITDA $635-675M, Adj. EPS $3.10-3.40.
Added 106 beds in Q1; plans to open 4 new inpatient facilities and at least 6 CTCs in 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2023 results: revenue $704.3 million, net income $66.0 million, EPS $0.72 per diluted share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2023
Revenue: $704.3 million
Net income: $66.0 million
EPS: $0.72 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

The Company reported revenue of $704.3 million for the first quarter of 2023, compared with $616.7 million for the first quarter of 2022.

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-000620

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.